Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-SET antibody (Catalog #: ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Hintergrund
SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alias Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
Protein Interaction Partner: ANP32A,APEX1,CDK5,CDK5R1,CDKN1A,ELAVL1,EP300,GZMA,HIST2H4A,HIST3H3,HMGB2,KLF5,MLL,NME1,PPP2CA,PPP2R1B,PTMA,RAC1,SET,SETBP1,SGOL1,TAF1A,THAP7,ANP32A,APEX1,CDK5R1,CDKN1A,DGKE,GZMA,HIST3H3,HIST4H4,HMGB2,KLF5,MEPCE,NME1,OTUD5,RGS20,SETBP1,TAF1A,THAP7,USP17L2,USP46,WDR48